Coley Pharmaceutical Group
Therapeutics and drug candidates to fight cancers, asthma, allergy and autoimmune disorders.
Employees
Enterprise value
$164m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
$164m Valuation: $164m | Acquisition | ||
| Total Funding | 000k | ||
Thuja Capital(exited)
Global Life Science Ventures(exited)
Techno Venture Management(exited)
Venrock(exited)
Qiagen(exited)
Alafi Capital(exited)
Thomas McNerney & Partners(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads